Skip to Main Content
Menu Button
About Us
Our Team
Careers
Technology
Clinical Pipeline
News
Contact
Oct. 14, 2024
Brand Icon
On 14 Oct
2024,
the
China
CDE officially approved the investigational new drug application of Suzhou
Fuent
Pharmaceutcal
Co.,
Ltd.，
with
the CDE acceptance number: CXSL2400508.
Recent news & press
2026
Prof Wang was invited to attend Tigermed's ASCO Pre-Event Webinar as a Speaker to introduce...
Learn More
Apr. 2026
no infusion related reaction (IRR) has occurred during the 48-hour continuous infusion by pump, this...
Learn More
